Pharmaceutical costs are on the rise, and we're here to help
Increasing Specialty Drug Costs
ACMS is uniquely qualified to help reduce the cost curve of specialty drugs for clients at a time such methods are sorely needed.
In 2020, the United States spent over $348 billion on prescription drugs, a number expected to rise to $863 billion by 2028, comprising 9% total US health expenditures. Despite being a smaller fraction of US prescriptions than non-specialty drugs, specialty drugs accounted for over half (53%) of U.S. prescription drug spending in 2021. Furthermore, experts expect a 2022 increase in specialty drug prices of 13.4%, compared to a 4.6% rise in non-specialty drug prices. Moreover, 40% of new products are specialty medications, increasing price inflation likely continuing the trend into future years.
Contact us to learn more about how we can help manage your specialty drug costs.
Client Centric
We work to make our cost reduction strategies work for you. Your business, your goals.
Devoted Service
Each employee has a true vested interest in pharmaceutical cost management. Our staff has a passion for finding solutions, not bandages.
Promoting Growth
Our methodology, combined with our passionate workers, network, and experts, makes us optimal catalysts for promoting growth in our clients.